...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: The Worst

Another month flies by with ... wait for it ... NOTHING from Zenith.  Surprised?  Nope.  I wonder why there are employees?  This (with RVX) is the worst investment I've ever made.  Hopefully I will learn from it and not ever repeat the folly.

Share
New Message
Please login to post a reply